History | Naltrexone for the management of opioid dependence | Guidance | NICE

History

Background information

Drug misuse - naltrexone: review decision - November 2010 information
Drug misuse - naltrexone: appendix A - review decision paper considered by the Institute's Guidance Executive (PDF 196 KB)

Published:

02 November 2010
TA115 Drug misuse - naltrexone: appendix A - provisional matrix of stakeholders (PDF 57 KB)

Published:

31 August 2010
TA115 Drug misuse - naltrexone: appendix B - proposal paper presented to the Institute's Guidance Executive (PDF 116 KB)

Published:

31 August 2010

Drug misuse - naltrexone: Final appraisal determination

Drug misuse - naltrexone: Final appraisal determination information
Drug misuse - naltrexone: Final appraisal determination document (PDF 81 KB)

Published:

16 October 2006
Drug misuse - naltrexone: Response to consultee and commentator comments on the ACD (PDF 47 KB)

Published:

16 October 2006
Consultee and commentator comments on the appraisal consultation document
Drug misuse - naltrexone, consultee and commentator comments: Welsh Assembly Government (PDF 71 KB)

Published:

16 October 2006
Drug misuse - naltrexone, consultee and commentator comments: Specialist Clinical Addiction Network (PDF 17 KB)

Published:

16 October 2006
Drug misuse - naltrexone, consultee and commentator comments: Royal College of Psychiatrists (PDF 14 KB)

Published:

16 October 2006
Drug misuse - naltrexone, consultee and commentator comments: Royal College of Nursing (PDF 13 KB)

Published:

16 October 2006
Drug misuse - naltrexone, consultee and commentator comments: NHS Quality Improvement Scotland (PDF 24 KB)

Published:

16 October 2006
Drug misuse - naltrexone, consultee and commentator comments: Department of Health, Social Service and Public Safety (revised) (PDF 77 KB)

Published:

16 October 2006
Drug misuse - naltrexone, consultee and commentator comments: Department of Health, Social Service and Public Safety (PDF 63 KB)

Published:

16 October 2006
Drug misuse - naltrexone, consultee and commentator comments: British Association for Psychopharmacology (PDF 16 KB)

Published:

16 October 2006

Drug misuse - naltrexone: Appraisal consultation document

Drug misuse - naltrexone: Appraisal consultation document information

Drug misuse - naltrexone: Evaluation report

Drug misuse - naltrexone: Evaluation report
Overview (PDF 103 KB)

Published:

30 June 2006
Assessment report (PDF 1.15 MB)

Published:

30 June 2006
Pinson (PDF 39 KB)

Published:

30 June 2006
Non-manufacturer submissions
Royal College of Psychiatrists (PDF 18 KB)

Published:

30 June 2006
Royal College of Nursing (PDF 34 KB)

Published:

30 June 2006
Royal College of General Practitioners (PDF 16 KB)

Published:

30 June 2006
Association of Nurses in Substance Abuse (ANSA) (PDF 22 KB)

Published:

30 June 2006
Bristol-Myers Squibb Pharmaceuticals (PDF 17 KB)

Published:

30 June 2006
Consultee and commentator comments on the assessment report
Welsh Assembly Government (WAG) (PDF 31 KB)

Published:

30 June 2006
SCAN (PDF 22 KB)

Published:

30 June 2008
Royal College of Psychiatrists (PDF 18 KB)

Published:

30 June 2006
Royal College of Nursing (PDF 45 KB)

Published:

30 June 2006
Royal College of General Practitioners (PDF 18 KB)

Published:

30 June 2006
Quality Improvement Scotland (NHS) (PDF 23 KB)

Published:

30 June 2006
British Association for Psychopharmacology (PDF 14 KB)

Published:

30 June 2006

Drug misuse - naltrexone: final protocol

Drug misuse - naltrexone: final protocol (PDF 92 KB)

Published:

17 August 2005

Drug misuse - naltrexone: Final scope

Drug misuse - naltrexone: Final scope (PDF 38 KB)

Published:

09 August 2005

Drug misuse - naltrexone: comments on draft scope

(Archive) Drug misuse - naltrexone: Draft scope (PDF 27 KB)

Published:

12 May 2005

(Archive) Drug misuse - naltrexone: Draft scope

(Archive) Drug misuse - naltrexone: Draft scope (PDF 27 KB)

Published:

12 May 2005

(Archive) Drug misuse - naltrexone: Provisional list of consultees and commentators

(Archive) Drug misuse - naltrexone: Provisional list of consultees and commentators (PDF 29 KB)

Published:

12 May 2005

2004/027 NICE asked to develop guidance on the care of drug misuse, medicines for prostate cancer, and management of attention deficit hyperactivity disorder

2004/027 NICE asked to develop guidance on the care of drug misuse, medicines for prostate cancer, and management of attention deficit hyperactivity disorder information